Apolipoprotein e influences melatonin biosynthesis by regulating NAT and MAOA expression in C6 cells

Journal of Pineal Research

Volumn 52, Issue 4, 2012, Pages 397-402

  Liu, Ya Jing ^a   Meng, Fan Tao ^a   Wang, Li Li ^a   Zhang, Li Feng ^a   Cheng, Xin Ping ^a   Zhou, Jiang Ning ^a  

^a UNIVERSITY OF SCIENCE AND TECHNOLOGY OF CHINA   (China)

Author keywords

apolipoprotein E; melatonin; monoamine oxidase A; monoamine oxidase B; N acetyltransferase

Indexed keywords

ACYLTRANSFERASE; AMINE OXIDASE (FLAVIN CONTAINING); AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME A; AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME B; APOLIPOPROTEIN E; MELATONIN; MESSENGER RNA;

ANIMAL CELL; ARTICLE; ASTROCYTE; BIOSYNTHESIS; COMPARATIVE STUDY; ENZYME SYNTHESIS; GENOTYPE; GLIOMA; NONHUMAN; PROTEIN EXPRESSION; RAT;

ANIMALS; APOLIPOPROTEINS E; ARYLAMINE N-ACETYLTRANSFERASE; ASTROCYTES; BLOTTING, WESTERN; CELL LINE, TUMOR; CELLS, CULTURED; FLOW CYTOMETRY; GENOTYPE; HUMANS; ISOENZYMES; MELATONIN; MONOAMINE OXIDASE; RATS;

EID: 84862807720     PISSN: 07423098     EISSN: 1600079X     Source Type: Journal    
DOI: 10.1111/j.1600-079X.2011.00954.x     Document Type: Article

References (27)

1. Mahley RW,. Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. Science 1988; 240: 622-630.
2. Weisgraber KH,. Apolipoprotein E: structure-function relationships. Adv Protein Chem 1994; 45: 249-302.
3. Weisgraber KH, Rall SC JR, Mahley RW,. Human E apoprotein heterogeneity. Cysteine-arginine interchanges in the amino acid sequence of the apo-E isoforms. J Biol Chem 1981; 256: 9077-9083.
4. Strittmatter WJ, Saunders AM, Schmechel D, et al., Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc Natl Acad Sci U S A 1993; 90: 1977-1981.
5. Corder EH, Saunders AM, Strittmatter WJ, et al., Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 1993; 261: 921-923.
6. Liu RY, Zhou JN, Van Heerikhuize J, et al., Decreased melatonin levels in postmortem cerebrospinal fluid in relation to aging, Alzheimer's disease, and apolipoprotein E-epsilon4/4 genotype. J Clin Endocrinol Metab 1999; 84: 323-327.
7. Zhou JN, Liu RY, Kamphorst W, et al., Early neuropathological Alzheimer's changes in aged individuals are accompanied by decreased cerebrospinal fluid melatonin levels. J Pineal Res 2003; 35: 125-130.
8. Boyles JK, Pitas RE, Wilson E, et al., Apolipoprotein E associated with astrocytic glia of the central nervous system and with nonmyelinating glia of the peripheral nervous system. J Clin Invest 1985; 76: 1501-1513.
9. Poirier J, Hess M, May PC, et al., Astrocytic apolipoprotein E mRNA and GFAP mRNA in hippocampus after entorhinal cortex lesioning. Brain Res Mol Brain Res 1991; 11: 97-106.
10. Liu YJ, Zhuang J, Zhu HY, et al., Cultured rat cortical astrocytes synthesize melatonin: absence of a diurnal rhythm. J Pineal Res 2007; 43: 232-238.
11. Reiter RJ,. Melatonin: the chemical expression of darkness. Mol Cell Endocrinol 1991; 79: C153-C158.
12. Reiter RJ,. The melatonin ryhthm: both a clock and a calendar. Experientia 1993; 49: 654-664.
13. Tan DX, Chen LD, Poeggeler B, et al., Melatonin: a potent, endogenous hydroxyl radical scavenger. Endocr J 1993; 1: 57-60.
14. Jou MJ, Peng TI, Reiter RJ, et al., Visualization of the antioxidative effects of melatonin at the mitochondrial level during oxidative stress-induced apoptosis of rat brain astrocytes. J Pineal Res 2004; 37: 55-70.
15. Reiter RJ,. Oxidative damage in the central nervous system: protection by melatonin. Prog Neurobiol 1998; 56: 359-384.
16. Galano A, Tan DX, Reiter RJ,. Melatonin as a natural ally against oxidative stress: a physicochemical examination. J Pineal Res 2011; 51: 1-16.
17. Baydas G, Ozveren F, Akdemir I, et al., Learning and memory deficits in rats induced by chronic thinner exposure are reversed by melatonin. J Pineal Res 2005; 39: 50-56.
18. Dong W, Huang F, Fan W, et al., Differential effects of melatonin on amyloid-beta peptide 25-35-induced mitochondrial dysfunction in hippocampal neurons at different stages of culture. J Pineal Res 2010; 48: 117-125.
19. Dragicevic N, Copes N, O'Neal-Moffitt G, et al., Melatonin treatment restores mitochondrial function in Alzheimer's mice: a mitochondrial protective role of melatonin membrane receptor signaling. J Pineal Res 2011; 51: 75-86.
20. Reiter RJ,. Pineal melatonin: cell biology of its synthesis and of its physiological interactions. Endocr Rev 1991; 12: 151-180.
21. Stehle JH, Saade A, Rawashdeh O, et al., A survey of molecular details in the human pineal gland in the light of phylogeny, structure, function and chronobiological diseases. J Pineal Res 2011; 51: 17-43.
22. Wu YH, Feenstra MG, Zhou JN, et al., Molecular changes underlying reduced pineal melatonin levels in Alzheimer disease: alterations in preclinical and clinical stages. J Clin Endocrinol Metab 2003; 88: 5898-5906.
23. Mondadori CR, De Quervain DJ, Buchmann A, et al., Better memory and neural efficiency in young apolipoprotein E epsilon4 carriers. Cereb Cortex 2007; 17: 1934-1947.
24. Filippini N, Macintosh BJ, Hough MG, et al., Distinct patterns of brain activity in young carriers of the APOE-epsilon4 allele. Proc Natl Acad Sci U S A 2009; 106: 7209-7214.
25. Marchant NL, King SL, Tabet N, et al., Positive effects of cholinergic stimulation favor young APOE epsilon4 carriers. Neuropsychopharmacology 2010; 35: 1090-1096.
26. Wozniak MA, Itzhaki RF, Faragher EB, et al., Apolipoprotein E-epsilon 4 protects against severe liver disease caused by hepatitis C virus. Hepatology 2002; 36: 456-463.
27. Meng FT, Wang YL, Liu J, et al., ApoE genotypes are associated with age at natural menopause in Chinese females. Age (Dordr) 2011; doi:.